T1D Scout is a health technology company offering at-home genetic screening to estimate an individual's risk of developing Type 1 Diabetes (T1D). Using a simple saliva swab, the service analyzes genetic markers to provide a personalized risk score, aiming to enable earlier detection and proactive health management. The company provides a clear, accessible alternative to traditional blood-based testing, with a focus on supporting families and individuals with a history of the condition.
Funding
Funding not disclosed
Founders
Product
Problem
Type 1 diabetes (T1D) is often diagnosed only after a serious complication like diabetic ketoacidosis (DKA), as many people are unaware of their elevated genetic risk. Traditional risk assessment can be complex and intimidating, often requiring blood tests and clinical visits, which creates a barrier to early screening and proactive monitoring.
Solution
T1D Scout provides a simple, at-home genetic screening kit that uses a painless saliva swab to estimate an individual's inherited risk for developing Type 1 diabetes. The service analyzes approximately 50 genetic markers, including those in the HLA region, to generate a personalized risk score. This score helps families and individuals understand their likelihood of developing T1D, enabling them to have informed conversations with healthcare providers and access early monitoring. For those identified as higher risk, T1D Scout offers complimentary follow-up support, including autoantibody testing and genetic counseling, to help manage their health proactively.
Target Audience
The primary audience is individuals with a family history of Type 1 diabetes, including parents of young children, siblings of those diagnosed, and adults curious about their own risk. The service is also designed for parents or legal guardians to register and manage testing for their children.
Features
- Analyzes ~50 genetic markers, including HLA and non-HLA regions, to calculate a combined genetic risk score.
- Simple, painless saliva-based sample collection that can be done at home with no needles or lab visits.
- Secure online portal for tracking sample status and receiving results in approximately 2-3 weeks.
- Includes complimentary 1-on-1 genetic counseling sessions for individuals classified as higher risk.
- Provides follow-up autoantibody testing at no additional cost for high-risk participants to aid in early detection.
- Offers specialist referrals and psychosocial support resources for those with elevated risk.